These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma. Wang Q, Chen Q, Zhang X, Lu XL, Du Q, Zhu T, Zhang GY, Wang DS, Fan QM. World J Gastroenterol; 2019 Sep 28; 25(36):5515-5529. PubMed ID: 31576097 [Abstract] [Full Text] [Related]
4. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK. World J Gastroenterol; 2015 Apr 07; 21(13):3928-35. PubMed ID: 25852278 [Abstract] [Full Text] [Related]
8. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A. Panminerva Med; 2017 Dec 07; 59(4):283-289. PubMed ID: 28650134 [Abstract] [Full Text] [Related]
10. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion. Poté N, Cauchy F, Albuquerque M, Voitot H, Belghiti J, Castera L, Puy H, Bedossa P, Paradis V. J Hepatol; 2015 Apr 07; 62(4):848-54. PubMed ID: 25450201 [Abstract] [Full Text] [Related]
11. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R. Am J Gastroenterol; 2000 Apr 07; 95(4):1036-40. PubMed ID: 10763956 [Abstract] [Full Text] [Related]
12. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients. Viggiani V, Palombi S, Gennarini G, D'Ettorre G, De Vito C, Angeloni A, Frati L, Anastasi E. Scand J Gastroenterol; 2016 Oct 07; 51(10):1257-62. PubMed ID: 27227515 [Abstract] [Full Text] [Related]
13. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R, Wang B, Ding H, Shen H, Li Y, Chen X. Chin Med J (Engl); 2002 Jan 07; 115(1):42-5. PubMed ID: 11930656 [Abstract] [Full Text] [Related]
17. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B. Yang T, Xing H, Wang G, Wang N, Liu M, Yan C, Li H, Wei L, Li S, Fan Z, Shi M, Chen W, Cai S, Pawlik TM, Soh A, Beshiri A, Lau WY, Wu M, Zheng Y, Shen F. Clin Chem; 2019 Dec 07; 65(12):1543-1553. PubMed ID: 31672853 [Abstract] [Full Text] [Related]
19. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. J Gastroenterol Hepatol; 2008 Oct 07; 23(10):1541-8. PubMed ID: 18422961 [Abstract] [Full Text] [Related]